Hebei, China
Business Type:
Manufacturer/Factory & Trading Company
Year of Establishment:
2002-06-11
Number of Employees:
82
Management System Certification:
ISO9001:2015, ISO45001:2018, ISO14001
Address:
South District of ShangZhuang Industry Zone, Shijiazhuang City, Hebei, China
OEM/ODM Service
Sample Available
Secured Trading Service

Ivermectin Injection, Oxytetracycline Injection, Tylosin Tartrate Injection manufacturer / supplier in China, offering Veterinary Poultry Chicken Bromhexine Menthol Oral Solution, Compound Bromhexine Oral Solution Excellent Expectorant for Farm Poultry Use, Bromhexine and Menthol Oral Solution for Poultry and so on.

Diamond Member Since 2020

Suppliers with verified business licenses

Info marked by is verified by BV

Contact Supplier

Mr. Jimmy Liu
General Manager

Company Profile

Watch Video
Shijiazhuang Shimu Pharmaceutical Co., Ltd.
Shijiazhuang Shimu Pharmaceutical Co., Ltd.
Shijiazhuang Shimu Pharmaceutical Co., Ltd.
Shijiazhuang Shimu Pharmaceutical Co., Ltd.
Business Type: Manufacturer/Factory & Trading Company
Main Products: ‪Ivermectin Injection‬ , ‪Oxytetracycline‬ , ‪Tylosin Tartrate Injection‬ , ‪Albendazole Bolus‬ , ‪...‬
Year of Establishment: 2002-06-11
Number of Employees: 82
Management System Certification: ISO9001:2015, ISO45001:2018, ISO14001
Address: South District of ShangZhuang Industry Zone, Shijiazhuang City, Hebei, China
BV Audit Report No. :

Shimu group was founded in 2001, located in Shijiazhuang high-tech industrial zone, including Shijiazhuang Shimu Animal Pharmaceutical Co., Ltd, Hebei Tianqiong International Trade Co., Ltd, Hebei Huamu Tianhe Biological technology Co., Ltd, three pillar industries. Shimu group is a comprehensive high-tech enterprise specialized in R&D, production, marketing and technical service. The first phase project was completed in 2005, and got the GMP certification successfully. So far we have 6 production line, including powder, premix, pulvis, oral solution, disinfectant, insecticide. In 2012 and 2017, Shimu passed GMP inspection routinely by China Ministry of Agriculture. For now the second phase project is under construction, the tablet, granules, injection, powder for injection, intramammary infusion, Intrauterine infusion will bring into production in June, 2018.

Shimu mainly produce veterinary drug and feed additive for poultry and livestock with more than 200 different specification products.

The company constantly improve the product structure, "to create Shimu brand, carving enterprise elite" as business goals, to ensure that products meet the market requirement, the company is using the major agricultural and animal husbandry institutions, research institutes as the basis. Shimu group with China Agricultural University, Northwest University, Hebei Agricultural University to establish long-term scientific research cooperation. In the product research and development, clinical trials, the use of products and promotion play a pivotal role. And strong technical strength and strong corporate strength to lay a solid foundation for improve the product structure, advanced technology, stable quality and effective in treatment.

Shimu has been focused on research and development for many years and the investment in R&D increase with years. After years of research and development had fruitful result. We have 5 municipal key scientific research projects, 5 research project award, 1 paper, 3 patent.

In recent years, the company has awarded many honors, like "Well Known Trademark of Hebei", "Quality products of Hebei ", "One of China largest 100 integrity companies" "China Animal Husbandry Association member units", "Hebei Province Animal Health Association vice president of the unit", etc.

Since the creation of the company, adhere to the "All for the customers, customer satisfaction is our pursuit" as business philosophy and "Co-Creation, Share the Value" as the purpose of the enterprise. Over the past few years, in serving the Chinese animal husbandry industry at the same time, the company has also made a thriving development, sales success.

General Information

9 items verified by BV
Business Type:
Manufacturer/Factory & Trading Company
Main Products:
Ivermectin Injection, Oxytetracycline, Tylosin Tartrate Injection, Albendazole Bolus, ...
Year of Establishment:
2002-06-11
Number of Employees:
82
Management System Certification:
ISO9001:2015, ISO45001:2018, ISO14001
Cooperated with Fortune 500:
No
Repeat Buyers Choice:
50%~80%
Address:
South District of ShangZhuang Industry Zone, Shijiazhuang City, Hebei, China
Plant Area:
14000 square meters
Registered Capital:
100,000,000 RMB

Trade Capacity

All information verified by BV
Main Markets:
Southeast Asia/ Mideast, Africa, Domestic
Number of Foreign Trading Staff:
9
Supply Chain Partners:
15
Minimum Order Quantity:
1
International Commercial Terms(Incoterms):
FOB, CIF, CFR, EXW
Terms of Payment:
LC, T/T, D/P, PayPal, Western Union
Average Lead Time:
Peak Season Lead Time: one month
Off Season Lead Time: one month
Overseas Agent/Branch:
No
Export Year:
9 years
Nearest Port:
Tianjin Port

Production Capacity

All information verified by BV
Production Lines:
14
Inspection Type for Finished Products:
Random inspection(Visual inspection & Function inspection)
Inspection Method for Finished Products:
Have instructions and uniformly followed
QA/QC Inspectors:
5 people
Traceability of Raw Materials:
Yes

R&D Capacity

All information verified by BV
Own Brand:
Yes
ODM Service Available:
Yes
OEM Service Available:
Yes
R&D Engineers:
10 people
New Products Launched in Last Year:
Yes
Customization Options:
Customization from Samples, Customization from Designs, Full Customization, Minor Customization, Flexible customization
Production Machines:
Tablet pressing machine, HPLC

Company Show

Send your message to this supplier

*From:
*To:
avatar Mr. Jimmy Liu
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now